CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Mar. 27, 2021	Mar. 28, 2020	Mar. 30, 2019
Cash flows from operating activities
Net (loss) income	$ (63)	$ (225)	$ 542
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	212	249	225
Share-based compensation expense	71	70	60
Impairment of assets	316	708	21
Credit loss	(3)	29	4
Losses on store lease exits	0	0	18
Deferred income taxes	(70)	(73)	(71)
Changes to lease related balances, net	(112)	(55)
Amortization of deferred financing costs	6	8	4
Tax deficit (benefit) on exercise of share options	4	2	(24)
Foreign currency (gains) losses	(15)	11	80
Other non-cash charges	0	3	0
Change in assets and liabilities:
Receivables, net	(52)	42	(23)
Inventories, net	145	115	(125)
Prepaid expenses and other current assets	(31)	20	(31)
Accounts payable	50	63	(48)
Accrued expenses and other current liabilities	153	(95)	20
Other long-term assets and liabilities	13	(13)	42
Net cash provided by operating activities	624	859	694
Cash flows from investing activities
Capital expenditures	(111)	(223)	(181)
Purchase of intangible assets	0	0	(3)
Cash paid for asset/business acquisitions, net of cash acquired	(13)	(13)	(1,875)
Realized loss on hedge related to acquisitions	0	0	(77)
Settlement of net investment hedges	0	298	11
Net cash (used in) provided by investing activities	(124)	62	(2,125)
Cash flows from financing activities
Debt borrowings	2,443	2,282	4,204
Debt repayments	(3,311)	(2,676)	(2,560)
Debt issuance costs	(4)	(1)	(15)
Repurchase of common stock	(1)	(102)	(207)
Exercise of employee share options	3	0	29
Net cash (used in) provided by financing activities	(870)	(497)	1,451
Effect of exchange rate changes on cash and cash equivalents	12	(4)	(11)
Net (decrease) increase in cash, cash equivalents and restricted cash	(358)	420	9
Beginning of period	592	172	163
End of period	234	592	172
Supplemental disclosures of cash flow information
Cash paid for interest	52	80	45
Cash paid for income taxes	45	98	172
Supplemental disclosure of non-cash investing and financing activities
Accrued capital expenditures	$ 17	$ 30	$ 25